lipoxin a4 has been researched along with Cancer of Pancreas in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bathina, S; Das, UN | 1 |
| Chen, K; Chen, X; Duan, W; Han, L; Jiang, Z; Lei, J; Li, X; Ma, J; Ma, Q; Sun, L; Wang, Z; Xu, Q; Zhou, C; Zong, L | 1 |
| Heinrich, MA; Kuninty, PR; Prakash, J; Schnittert, J; Storm, G | 1 |
| Chen, K; Chen, X; Duan, W; Lei, J; Li, J; Li, W; Li, X; Ma, Q; Shan, T; Sun, H; Xu, Q; Zhang, L; Zong, L | 1 |
4 other study(ies) available for lipoxin a4 and Cancer of Pancreas
| Article | Year |
|---|---|
PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo.
Topics: Alloxan; Animals; Arachidonic Acid; Benzo(a)pyrene; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cytotoxins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Doxorubicin; Drug Interactions; Fatty Acids, Unsaturated; Insulin-Secreting Cells; Insulinoma; Lipoxins; Pancreatic Neoplasms; Rats; Rats, Wistar; Streptozocin | 2019 |
Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Topics: Animals; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Heterografts; Humans; Lipoxins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; Phenotype; Signal Transduction; Transforming Growth Factor beta1 | 2017 |
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cellular Reprogramming; Collagen Type I; Combined Modality Therapy; Gene Expression Regulation, Neoplastic; Humans; Lipoxins; Mice; Pancreatic Neoplasms; Pancreatic Stellate Cells; Paracrine Communication; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |
Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer.
Topics: Cell Line, Tumor; Humans; Lipoxins; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Reactive Oxygen Species | 2016 |